martes, 16 de agosto de 2022

Prespecified secondary analysis of randomized trial of dapagliflozin vs placebo in 17,160 patients

Prespecified secondary analysis of randomized trial of dapagliflozin vs placebo in 17,160 patients

No hay comentarios:

Publicar un comentario